Increased plasma peroxides and serum oxidized low density lipoprotein antibodies in major depression: Markers that further explain the higher incidence of neurodegeneration and coronary artery disease

Journal of Affective Disorders

Volumn 125, Issue 1-3, 2010, Pages 287-294

  Maes, Michael ^a   Mihaylova, Ivanka ^a   Kubera, Marta ^b   Uytterhoeven, Marc ^c   Vrydags, Nicolas ^c   Bosmans, Eugene ^c  

^a Maes Clinics   (Belgium)

^b INSTITUTE OF PHARMACOLOGY   (Poland)

^c AML Laboratory   (Belgium)

Author keywords

Antioxidants; Cardiovascular disorders; Cytokines; Inflammation; Neurodegeneration; Oxidative stress

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; CITALOPRAM; CREATININE; ESCITALOPRAM; FLUOXETINE; NITROGEN; OXIDIZED LOW DENSITY LIPOPROTEIN ANTIBODY; PAROXETINE; PEROXIDE; PROTEIN; SERTRALINE; THYROTROPIN; UREA; VENLAFAXINE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BLOOD SAMPLING; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROL GROUP; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CREATININE BLOOD LEVEL; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE SEVERITY; FEMALE; FIBROMYALGIA AND CHRONIC FATIGUE SYNDROME RATING SCALE; GASTROINTESTINAL SYMPTOM; HAMILTON SCALE; HEADACHE; HUMAN; LIPID PEROXIDATION; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; NERVE DEGENERATION; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RATING SCALE; THYROTROPIN BLOOD LEVEL; UREA NITROGEN BLOOD LEVEL;

ADULT; AUTOANTIBODIES; BIOLOGICAL MARKERS; COMORBIDITY; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDIES; DEPRESSIVE DISORDER, MAJOR; FATIGUE SYNDROME, CHRONIC; FEMALE; GASTROINTESTINAL DISEASES; HEADACHE; HUMANS; INCIDENCE; LIPID PEROXIDATION; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; NEURODEGENERATIVE DISEASES; OXIDATIVE STRESS; PEROXIDES; REFERENCE VALUES; SOMATOFORM DISORDERS;

EID: 77955556964     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2009.12.014     Document Type: Article

References (77)

1. R.M. Adibhatla, and J.F. Hatcher Phospholipase A(2), reactive oxygen species, and lipid peroxidation in CNS pathologies BMB Rep. 41 8 2008 560 567
2. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Text Revision (DSM-IV-TR) 2000 Washington DC
3. A.C. Andreazza, B.N. Frey, B. Erdtmann, M. Salvador, F. Rombaldi, A. Santin, C.A. Gonçalves, and F. Kapczinski DNA damage in bipolar disorder Psychiatry Res. 153 1 2007 27 32
4. S. Arlt, A. Kontush, T. Müller-Thomsen, and U. Beisiegel Lipid peroxidation as a common pathomechanism in coronary heart disease and Alzheimer disease Z. Gerontol. Geriatr. 34 6 2001 461 465
5. S. Arlt, U. Beisiegel, and A. Kontush Lipid peroxidation in neurodegeneration: new insights into Alzheimer's disease Curr. Opin. Lipidol. 13 3 2002 289 294
6. M. Berk, D.L. Copolov, O. Dean, K. Lu, S. Jeavons, I. Schapkaitz, M. Anderson-Hunt, and A.I. Bush N-acetyl cysteine for depressive symptoms in bipolar disorder a double-blind randomized placebo-controlled trial Biol. Psychiatry 64 6 2008 468 475
7. S. Bonaccorso, V. Marino, A. Puzella, M. Pasquini, M. Biondi, M. Artini, C. Almerighi, R. Verkerk, H. Meltzer, and M. Maes Increased depressive ratings in patients with hepatitis C receiving interferon-alpha-based immunotherapy are related to interferon-alpha-induced changes in the serotonergic system J. Clin. Psychopharmacol. 22 1 2002 86 90
8. S. Campbell, and G. MacQueen An update on regional brain volume differences associated with mood disorders Curr. Opin. Psychiatry 19 1 2006 25 33
9. C. Dickens, L. McGowan, C. Percival, B. Tomenson, L. Cotter, A. Heagerty, and F. Creed New onset depression following myocardial infarction predicts cardiac mortality Psychosom. Med. 70 4 2008 450 455
10. N. Dimopoulos, C. Piperi, V. Psarra, R.W. Lea, and A. Kalofoutis Increased plasma levels of 8-iso-PGF2alpha and IL-6 in an elderly population with depression Psychiatry Res. 161 1 2008 59 66
11. R. Edwards, M. Peet, J. Shay, and D. Horrobin Omega-3 polyunsaturated fatty acid levels in the diet and in red blood cell membranes of depressed patients J. Affect. Disord. 48 2-3 1998 149 155 (Pubitemid 28244216)
12. I. Eren, M. Naziroǧglu, and A. Demirdas Protective effects of lamotrigine, aripiprazole and escitalopram on depression-induced oxidative stress in rat brain Neurochem. Res. 32 7 2007 1188 1195
13. I. Eren, M. Naziroǧglu, A. Demirdaşs, O. Celik, A.C. Uǧguz, A. Altunbaşsak, I. Ozmen, and E. Uz Venlafaxine modulates depression-induced oxidative stress in brain and medulla of rat Neurochem. Res. 32 3 2007 497 505
14. Z. Feng, W. Hu, L.J. Marnett, and M.S. Tang Malondialdehyde, a major endogenous lipid peroxidation product, sensitizes human cells to UV-and BPDE-induced killing and mutagenesis through inhibition of nucleotide excision repair Mutat. Res. 601 1-2 2006 125 136
15. M.J. Forlenza, and G.E. Miller Increased serum levels of 8-hydroxy-2′-deoxyguanosine in clinical depression Psychosomatic Med. 68 1 2006 1 7
16. P. Galecki, J. Szemraj, M. Bieńnkiewicz, A. Florkowski, and E. Gałlecka Lipid peroxidation and antioxidant protection in patients during acute depressive episodes and in remission after fluoxetine treatment Pharmacol. Rep. 61 3 2009 436 447
17. 2 and Jak2-independent antioxidant features of the Jak2 inhibitor AG490 Glia 55 13 2007 1313 1324
18. I. Goshen, T. Kreisel, O. Ben-Menachem-Zidon, T. Licht, J. Weidenfeld, T. Ben-Hur, and R. Yirmiya Brain interleukin-1 mediates chronic stress-induced depression in mice via adrenocortical activation and hippocampal neurogenesis suppression Mol. Psychiatry 13 7 2008 717 728
19. P. Gounopoulos, E. Merki, L.F. Hansen, S.H. Choi, and S. Tsimikas Antibodies to oxidized low density lipoprotein: epidemiological studies and potential clinical applications in cardiovascular disease Minerva Cardioangiol. 55 6 2007 821 837
20. M. Hamilton A rating scale for depression J. Neurol. Neurosurg. Psychiatry 23 1960 56 61
21. J. Haorah, K. Schall, S.H. Ramirez, and Y. Persidsky Activation of protein tyrosine kinases and matrix metalloproteinases causes blood-brain barrier injury: novel mechanism for neurodegeneration associated with alcohol abuse Glia 56 1 2008 78 88
22. K.L. Huang, T.P. Su, T.J. Chen, Y.H. Chou, and Y.M. Bai Comorbidity of cardiovascular diseases with mood and anxiety disorder: a population based 4-year study Psychiatry Clin. Neurosci. 63 3 2009 401 409
23. J. Hulthe Antibodies to oxidized LDL in atherosclerosis development-clinical and animal studies Clin. Chim. Acta 348 1-2 2004 1 8
24. V. Katalinic, D. Modun, I. Music, and M. Boban Gender differences in antioxidant capacity of rat tissues determined by 2, 2′-azinobis (3-ethylbenzothiazoline 6-sulfonate; ABTS) and ferric reducing antioxidant power (FRAP) assays Comp. Biochem. Physiol. C. Toxicol. Pharmacol. 140 1 2005 47 52
25. S.D. Khanzode, G.N. Dakhale, S.S. Khanzode, A. Saoji, and R. Palasodkar Oxidative damage and major depression: the potential antioxidant action of selective serotonin re-uptake inhibitors Redox Rep. 8 6 2003 365 370
26. K. Kobayashi, L.R. Lopez, Y. Shoenfeld, and E. Matsuura The role of innate and adaptive immunity to oxidized low-density lipoprotein in the development of atherosclerosis Ann. N. Y. Acad. Sci. 1051 2005 442 454
27. Kodydková, J., Vávrová, L., Zeman, M., Jirák, R., Macášek, J., Stanková, B., Tvrzická, E., Zák, A., 2009. Antioxidative enzymes and increased oxidative stress in depressive women. Clin. Biochem. 42 (13-14), 1368-1374.
28. J.W. Koo, and R.S. Duman IL-1beta is an essential mediator of the antineurogenic and anhedonic effects of stress Proc. Nat. Acad. Sci. U. S. A. 105 2008 751 756
29. G. Lucca, C.M. Comim, S.S. Valvassori, G.Z. Réus, F. Vuolo, F. Petronilho, F. Dal-Pizzol, E.C. Gavioli, and J. Quevedo Effects of chronic mild stress on the oxidative parameters in the rat brain Neurochem. Int. 54 5-6 2009 358 362
30. G. Lucca, C.M. Comim, S.S. Valvassori, G.Z. Réus, F. Vuolo, F. Petronilho, E.C. Gavioli, F. Dal-Pizzol, and J. Quevedo Increased oxidative stress in submitochondrial particles into the brain of rats submitted to the chronic mild stress paradigm J. Psychiatr. Res. 43 9 2009 864 869
31. M. Maes Evidence for an immune response in major depression: a review and hypothesis Prog. Neuropsychopharmacol. Biol. Psychiatry 19 1 1995 11 38
32. M. Maes Major depression and activation of the inflammatory response system Adv. Exp. Med. Biol. 461 1999 25 46
33. M. Maes The cytokine hypothesis of depression: inflammation, oxidative & nitrosative stress (IO&NS) and leaky gut as new targets for adjunctive treatments in depression Neuro Endocrinol. Lett. 29 3 2008 287 291
34. Maes, M., 2009. "Functional" or "psychosomatic" symptoms, e.g. A flu-like malaise, aches and pain and fatigue, are major features of major and in particular of melancholic depression: time to amend the diagnostic criteria for major depression and the rating scales that measure severity of illness. Neuro Endocrinol Lett. 30 (5) (nov).
35. M. Maes, and J.C. Leunis Normalization of leaky gut in chronic fatigue syndrome (CFS) is accompanied by a clinical improvement: effects of age, duration of illness and the translocation of LPS from gram-negative bacteria Neuro Endocrinol. Lett. 29 6 2008 902 910
36. M. Maes, E. Bosmans, E. Suy, C. Vandervorst, C. De Jonckheere, and J. Raus Immune disturbances during major depression: upregulated expression of interleukin-2 receptors Neuropsychobiology 24 3 1990-1991 115 120
37. M. Maes, E. Bosmans, E. Suy, C. Vandervorst, C. DeJonckheere, and J. Raus Depression-related disturbances in mitogen-induced lymphocyte responses and interleukin-1 beta and soluble interleukin-2 receptor production Acta Psychiatr. Scand. 84 4 1991 379 386
38. M. Maes, E. Vandoolaeghe, H. Neels, P. Demedts, A. Wauters, H.Y. Meltzer, C. Altamura, and R. Desnyder Lower serum zinc in major depression is a sensitive marker of treatment resistance and of the immune/inflammatory response in that illness Biol. Psychiatry 42 5 1997 349 358
39. M. Maes, A. Christophe, J. Delanghe, C. Altamura, H. Neels, and H.Y. Meltzer Lowered omega3 polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients Psychiatry Res. 85 3 1999 275 291
40. M. Maes, N. De Vos, R. Pioli, P. Demedts, A. Wauters, H. Neels, and A. Christophe Lower serum vitamin E concentrations in major depression. Another marker of lowered antioxidant defenses in that illness J. Affect. Disord. 58 3 2000 241 246
41. M. Maes, I. Mihaylova, and J.C. Leunis Increased serum IgM antibodies directed against phosphatidyl inositol (Pi) in chronic fatigue syndrome (CFS) and major depression: evidence that an IgM-mediated immune response against Pi is one factor underpinning the comorbidity between both CFS and depression Neuro Endocrinol. Lett. 28 6 2007 861 867
42. M. Maes, M. Kubera, and J.C. Leunis The gut-brain barrier in major depression: intestinal mucosal dysfunction with an increased translocation of LPS from gram negative enterobacteria (leaky gut) plays a role in the inflammatory pathophysiology of depression Neuro Endocrinol. Lett. 29 1 2008 117 124
43. M. Maes, I. Mihaylova, and J.-C. Ategis Evidence for an IgM-mediated immune response directed against nitro-bovine serum albumin (BSA) in chronic fatigue syndrome (CFS) and major depression (MDD): evidence that the immune response to nitrosative stress-induced damage of BSA is more pronounced in CFS than in MDD Neuro Endocrinol. Lett. 29 2008 313 319
44. M. Maes, R. Yirmyia, J. Noraberg, S. Brene, J. Hibbeln, G. Perini, M. Kubera, P. Bob, B. Lerer, and M. Maj The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression Metab. Brain Dis. 24 1 2009 27 53
45. Maes, M., Mihaylova, I., Kubera, M., Uytterhoeven, M., Vrydags, N., Bosmans, E., 2009b. Lower plasma coenzyme Q10 in depression: a marker for treatment resistance and chronic fatigue in depression and a risk factor to cardiovascular disorder in that illness. Neuro Endocinol. Lett. 30 (4).
46. Maes, M., Mihaylova, I., Kubera, M., Uytterhoeven, M., Vrydags, N., Bosmans, E., submitted for publication. GPX lower whole blood glutathione peroxidase (GPX) activity in depression, but not in myalgic encephalomyelitis/ chronic fatigue syndrome: lower GPX activity as another pathway explaining the increased incidence of coronary artery disease in depression. Neuro Endocrinol. Lett.
47. Maes, M., Mihaylova, I., Kubera, M., Uytterhoeven, M., Vrydags, N., Bosmans, E., 2009c. Increased 8-hydroxy-deoxyguanosine, a marker of oxidative damage to DNA, in major depression and myalgic encephalomyelitis/chronic fatigue syndrome. Neuro Endocrinol Lett. 30 (6) (dec).
48. K. Mandal, M. Jahangiri, and Q. Xu Autoimmune mechanisms of atherosclerosis Handb. Exp. Pharmacol. 170 2005 723 743
49. A. Martínez, M. Carmona, M. Portero-Otin, A. Naudí, R. Pamplona, and I. Ferrer Type-dependent oxidative damage in frontotemporal lobar degeneration: cortical astrocytes are targets of oxidative damage J. Neuropathol. Exp. Neurol. 67 12 2008 1122 1136
50. E. Matsuura, and L.R. Lopez Autoimmune-mediated atherothrombosis Lupus 17 10 2008 878 887
51. E. Matsuura, G.R. Hughes, and M.A. Khamashta Oxidation of LDL and its clinical implication Autoimmun. Rev. 7 7 2008 558 566
52. T.M. Michel, S. Camara, T. Tatschner, S. Frangou, A.J. Sheldrick, P. Riederer, and E. Grunblatt Increased xanthine oxidase in the thalamus and putamen in depression World J. Biol. Psychiatry 12 2008 1 7
53. A. Müller, E. Cadenas, P. Graf, and H. Sies A novel biologically active seleno-organic compound-I. Glutathione peroxidase-like activity in vitro and antioxidant capacity of PZ 51 (Ebselen) Biochem. Pharmacol. 33 20 1984 3235 3239
54. A.J. Owen, M.J. Batterham, Y.C. Probst, B.F. Grenyer, and L.C. Tapsell Low plasma vitamin E levels in major depression: diet or disease? Eur. J. Clin. Nutr. 59 2 2005 304 306
55. M.E. Ozcan, M. Gulec, E. Ozerol, R. Polat, and O. Akyol Antioxidant enzyme activities and oxidative stress in affective disorders Int. Clin. Psychopharmacol. 19 2 2004 89 95
56. S.N. Pal, and P.C. Dandiya Glutathione as a cerebral substrate in depressive behavior Pharmacol. Biochem. Behav. 48 4 1994 845 851
57. T. Posser, M.P. Kaster, S.C. Baraúna, J.B. Rocha, A.L. Rodrigues, and R.B. Leal Antidepressant-like effect of the organoselenium compound ebselen in mice: evidence for the involvement of the monoaminergic system Eur. J. Pharmacol. 602 1 2009 85 91
58. L. Qin, X. Wu, M.L. Block, Y. Liu, G.R. Breese, J.S. Hong, D.J. Knapp, and F.T. Crews Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration Glia 55 5 2007 453 462
59. J.N. Rees, V.R. Florang, D.G. Anderson, and J.A. Doorn Lipid peroxidation products inhibit dopamine catabolism yielding aberrant levels of a reactive intermediate Chem. Res. Toxicol. 20 10 2007 1536 1542
60. A. Sarandol, E. Sarandol, S.S. Eker, S. Erdinc, E. Vatansever, and S. Kirli Major depressive disorder is accompanied with oxidative stress: short-term antidepressant treatment does not alter oxidative-antioxidative systems Hum. Psychopharmacol. 22 2 2007 67 73
61. T. Satoh, K. Ishige, and Y. Sagara Protective effects on neuronal cells of mouse afforded by ebselen against oxidative stress at multiple steps Neurosci. Lett. 371 1 2004 1 5
62. O.J. Schiepers, M.C. Wichers, and M. Maes Cytokines and major depression Prog. Neuropsychopharmacol. Biol. Psychiatry 29 2 2005 201 217
63. C.A. Shively, D.L. Musselman, and S.L. Willard Stress, depression, and coronary artery disease: modeling comorbidity in female primates Neurosci. Biobehav. Rev. 33 2 2009 133 144
64. M. Siwek, D. Dudek, I.A. Paul, M. Sowa-Kucma, A. Zieba, P. Popik, A. Pilc, and G. Nowak Zinc supplementation augments efficacy of imipramine in treatment resistant patients: a double blind, placebo-controlled study J Affect. Disord. 118 1-3 2009 187 195
65. T.C. Somberg, and R.R. Arora Depression and heart disease: therapeutic implications Cardiology 111 2 2008 75 81
66. C. Song, A.A. Killeen, and B.E. Leonard Catalase, superoxide dismutase and glutathione peroxidase activity in neutrophils of sham-operated and olfactory-bulbectomised rats following chronic treatment with desipramine and lithium chloride Neuropsychobiology 30 1 1994 24 28
67. A. Steinerová, J. Racek, F. Stozický, T. Zima, L. Fialová, and A. Lapin Antibodies against oxidized LDL-theory and clinical use Physiol. Res. 50 2 2001 131 141
68. C.A. Stockmeier, G.J. Mahajan, L.C. Konick, J.C. Overholser, G.J. Jurjus, H.Y. Meltzer, H.B. Uylings, L. Friedman, and G. Rajkowska Cellular changes in the postmortem hippocampus in major depression Biol. Psychiatry 56 9 2004 640 650
69. R. Sultana, M. Perluigi, and D.A. Butterfield Protein oxidation and lipid peroxidation in brain of subjects with Alzheimer's disease: insights into mechanism of neurodegeneration from redox proteomics Antioxid. Redox Signal. 8 11-12 2006 2021 2037
70. S. Tsimikas Oxidative biomarkers in the diagnosis and prognosis of cardiovascular disease Am. J. Cardiol. 98 11A 2006 9P 17P
71. O. Vaarala Antibodies to oxidised LDL Lupus 9 3 2000 202 205
72. N. Vanlangenakker, T.V. Berghe, D.V. Krysko, N. Festjens, and P. Vandenabeele Molecular mechanisms and pathophysiology of necrotic cell death Curr. Mol. Med. 8 3 2008 207 220
73. J.F. Wang, L. Shao, X. Sun, and L.T. Young Increased oxidative stress in the anterior cingulate cortex of subjects with bipolar disorder and schizophrenia Bipolar Disord. 11 5 2009 523 529
74. Y.C. Wei, F.L. Zhou, D.L. He, J.R. Bai, L.Y. Hui, X.Y. Wang, and K.J. Nan The level of oxidative stress and the expression of genes involved in DNA-damage signaling pathways in depressive patients with colorectal carcinoma J. Psychosom. Res. 66 3 2009 259 266
75. M.C. Wichers, G.H. Koek, G. Robaeys, R. Verkerk, S. Scharpé, and M. Maes IDO and interferon-alpha-induced depressive symptoms: a shift in hypothesis from tryptophan depletion to neurotoxicity Mol. Psychiatry 10 6 2005 538 544
76. O. Zachrisson, B. Regland, M. Jahreskog, M. Kron, and C.G. Gottfries A rating scale for fibromyalgia and chronic fatigue syndrome (the FibroFatigue scale) J. Psychosom. Res. 52 6 2002 501 509
77. F.L. Zhou, W.G. Zhang, Z.X. Su, X. Meng, and W. Tian Relationship between oxidative stress and depression in patients with acute leukemia Zhongguo Shi Yan Xue Ye Xue Za Zhi 14 5 2006 872 875